Factors Impacting All-cause Mortality in Men Receiving Androgen Deprivation Therapy with Prostate Brachytherapy

被引:0
|
作者
Taira, A. V. [1 ]
Merrick, G. S. [2 ]
Galbreath, R. W. [2 ]
Butler, W. M. [2 ]
Adamovich, E. [3 ]
Wallner, K. E. [4 ]
机构
[1] Univ Washington, Seattle, WA 98195 USA
[2] Schiffler Canc Ctr, Wheeling, WV USA
[3] Wheeling Hosp, Dept Pathol, Wheeling, WV USA
[4] Puget Sound Healthcare Corp, Seattle, WA USA
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2009年 / 75卷 / 03期
关键词
D O I
10.1016/j.ijrobp.2009.07.362
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S154 / S154
页数:1
相关论文
共 50 条
  • [31] Psychological distress in men with prostate cancer receiving adjuvant androgen-deprivation therapy
    Saini, Andrea
    Berruti, Alfredo
    Cracco, Cecilia
    Sguazzotti, Erica
    Porpiglia, Francesco
    Russo, Lucianna
    Bertaglia, Valentina
    Picci, Rocco Luigi
    Negro, Manuela
    Tosco, Alessandra
    Campagna, Sara
    Scarpa, Roberto Mario
    Dogliotti, Luigi
    Furlan, Pier Maria
    Ostacoli, Luca
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2013, 31 (03) : 352 - 358
  • [32] Osteoporosis in men receiving androgen deprivation therapy for non-metastatic prostate cancer
    Kudlacek, Stefan
    Puntus, Thomas
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 2012, 162 (17-18) : 380 - 385
  • [33] SEXUAL FUNCTION IN MEN RECEIVING ANDROGEN DEPRIVATION THERAPY FOR PROSTATE CANCER: A CONTROLLED COMPARISON
    Donovan, Kristine A.
    Cessna, Julie M.
    Phillips, Kristin M.
    Hussin, Mallory
    Jacobsen, Paul B.
    ANNALS OF BEHAVIORAL MEDICINE, 2012, 43 : S271 - S271
  • [34] Assessment and predictors of fatigue in men with prostate cancer receiving radiotherapy and androgen deprivation therapy
    Bandara, Vindya
    Capp, Anne
    Ahmed, Gias
    Arm, Jameen
    Martin, Jarad
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2019, 63 (05) : 683 - 690
  • [35] Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer Editorial Comment
    Walsh, Patrick C.
    JOURNAL OF UROLOGY, 2010, 183 (03): : 1012 - 1013
  • [36] Toremifene to Reduce Fracture Risk in Men Receiving Androgen Deprivation Therapy for Prostate Cancer
    Smith, Matthew R.
    Morton, Ronald A.
    Barnette, K. Gary
    Sieber, Paul R.
    Malkowicz, S. Bruce
    Rodriguez, Domingo
    Hancock, Michael L.
    Steiner, Mitchell S.
    JOURNAL OF UROLOGY, 2013, 189 (01): : S45 - S50
  • [37] Coronary Microvascular Dysfunction in Men with Prostate Cancer Receiving Androgen-Deprivation Therapy
    Welch, Erin
    Guerraty, Marie A.
    Demissei, Biniyam G.
    Haas, Naomi
    Takvorian, Samuel
    Parikh, Ravi B.
    Vaughn, David J.
    Pryma, Daniel
    Mankoff, David A.
    Ky, Bonnie
    Narayan, Vivek
    CLINICAL GENITOURINARY CANCER, 2024, 22 (04)
  • [38] Risk of esophageal and gastric adenocarcinoma in men receiving androgen deprivation therapy for prostate cancer
    Shore, Richard
    Yu, Jingru
    Ye, Weimin
    Lagergren, Jesper
    Rutegard, Martin
    Akre, Olof
    Stattin, Par
    Lindblad, Mats
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [39] Screening for Osteoporosis in Men Receiving Androgen Deprivation Therapy
    Alibhai, Shabbir M. H.
    Yun, Lingsong
    Cheung, Angela M.
    Paszat, Lawrence
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (03): : 255 - 256
  • [40] Long-term prostate cancer mortality, all-cause survival and morbidity following prostate brachytherapy
    Skouteris, V
    Stone, N.
    Sheu, R-D
    Stock, R.
    EUROPEAN UROLOGY, 2022, 81 : S1396 - S1397